In some human cancers, elevated expression levels of CSN5 and CSN6 are correlated with cancer progression and poor prognosis [148,188,189,190,191], which may be due to increased DDR function reducing the efficacy of cytotoxic therapies employing DNA damaging agents. This evidence concerns the gene COPS5 and cancer.